By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Mayne Group Limited 

Level 21/390 St Kilda Road

Melbourne  Victoria  3004  Australia
Phone: 613-9868-0700 Fax:




Maxim Pharmaceuticals, Inc. 

Company News
Mayne Pharma Failed To Report US Drug Reactions10/19/2005 5:12:41 PM
Mayne Pharma USA Inc. Adds Carboplatin Injection To Its Product Line 10/19/2005 5:11:50 PM
Mayne Pharma (AU:FHF) Announces Addition Of Fluconazole Injection Mini Bags To Its Product Line10/19/2005 5:11:20 PM
aaiPharma Inc. (AAII) Completes Asset Sale And Closes On New $140 Million Credit Facility; Company Achieves Financing Goals10/19/2005 5:11:03 PM
IVAX Corporation (IVX) Enters Marketing And Distribution Agreement With Mayne Pharmaceuticals For Injectable Paclitaxel In Europe10/19/2005 5:10:09 PM
Atrix Laboratories, Inc. (ATRX) Release: Eligard(R) Prostate Cancer Products Receive Approval In Australia10/19/2005 5:09:31 PM
NaPro BioTherapeutics (NPRO) Completes Sale Of Worldwide Paclitaxel Business To Mayne Pharma (AU:FHF); $71.7 Million Cash Minus An Inventory Adjustment Of $4.6 Million10/19/2005 5:09:30 PM
Mayne Pharma (AU:FHF) And Bristol-Myers Squibb Company (BMY) Seize Top Honors In National Skill-Building Competition10/19/2005 5:09:30 PM
Faulding Pharmaceutical Co. And Faulding Puerto Rico, Inc. Announces Change Of Its Corporate Names To Mayne Pharma (USA) Inc. And Mayne Pharma (Pr) Inc.10/19/2005 5:09:18 PM